Literature DB >> 12868293

Pain assessment in patients with possible vascular dementia.

Erik J A Scherder1, Joris Slaets, Jan-Berend Deijen, Yvonne Gorter, Marcel E Ooms, Miel Ribbe, Pieter-Jelle Vuijk, Karen Feldt, Marinus van de Valk, Anke Bouma, Joseph A Sergeant.   

Abstract

PREVIOUS studies comparing Alzheimer's disease (AD) patients with the normal elderly suggest that AD patients experience less pain. In the present study, pain reporting in 20 patients with possible vascular dementia (VaD) was compared to 20 nondemented elderly who had comparable pain conditions. It was hypothesized that, due to de-afferentiation, the possible VaD patients would experience more pain than the cognitively intact elderly. Pain assessment was conducted using three visual analogue scales, (1) the Coloured Analogue Scale (CAS) for Pain Intensity, (2) the CAS for Pain Affect, and (3) the Faces Pain Scale (FPS); a verbal pain questionnaire, Number of Words Chosen--Affective (NWC-A) of the McGill Pain Questionnaire; and an observation scale, the Checklist of Nonverbal Pain Indicators (CNPI). Results showed a significant increase in the scores on the CAS for Pain Affect and the FPS in the demented patients compared to the control group. There was a tendency for an increase in scores on the CNPI in the VaD group. These results suggest that patients with possible VaD suffer more pain than healthy elderly without cognitive impairment.

Entities:  

Mesh:

Year:  2003        PMID: 12868293     DOI: 10.1521/psyc.66.2.133.20618

Source DB:  PubMed          Journal:  Psychiatry        ISSN: 0033-2747            Impact factor:   2.458


  13 in total

1.  [The systematic evaluation of instruments designed to assess pain in persons with limited ability to communicate].

Authors:  Michèle Aubin; Anik Giguère; Thomas Hadjistavropoulos; René Verreault
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

2.  Pain medication and global cognitive functioning in dementia patients with painful conditions.

Authors:  Bart Plooij; Klaas van der Spek; Erik J A Scherder
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

Review 3.  Assessment and management of pain, with particular emphasis on central neuropathic pain, in moderate to severe dementia.

Authors:  Erik J A Scherder; Bart Plooij
Journal:  Drugs Aging       Date:  2012-09       Impact factor: 3.923

4.  Age-Related Changes in Headache Days across the Cognitive Spectrum.

Authors:  Karl Echiverri; Gregory A Jicha; Jonathan H Smith
Journal:  Pain Med       Date:  2018-07-01       Impact factor: 3.750

5.  Pain assessment in a geriatric psychiatry program.

Authors:  Paul Stolee; Loretta M Hillier; Jacquelin Esbaugh; Nancy Bol; Laurie McKellar; Nicole Gauthier; Maggie C Gibson
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

Review 6.  Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools.

Authors:  Sandra M G Zwakhalen; Jan P H Hamers; Huda Huijer Abu-Saad; Martijn P F Berger
Journal:  BMC Geriatr       Date:  2006-01-27       Impact factor: 3.921

Review 7.  Pain management in patients with dementia.

Authors:  Wilco P Achterberg; Marjoleine J C Pieper; Annelore H van Dalen-Kok; Margot W M de Waal; Bettina S Husebo; Stefan Lautenbacher; Miriam Kunz; Erik J A Scherder; Anne Corbett
Journal:  Clin Interv Aging       Date:  2013-11-01       Impact factor: 4.458

8.  The Assessment of Pain in Older People: UK National Guidelines.

Authors:  Pat Schofield
Journal:  Age Ageing       Date:  2018-03-01       Impact factor: 10.668

Review 9.  Pharmacological pain management in the elderly patient.

Authors:  Gary McCleane
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

10.  Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial.

Authors:  R K Sandvik; G Selbaek; R Seifert; D Aarsland; C Ballard; A Corbett; B S Husebo
Journal:  Eur J Pain       Date:  2014-05-13       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.